Connect to other sites within the UBM Medica Network
Want to maximize the benefits and reduce potential harms of cervical cancer screening? Try these 4 strategies.
New HPV Vaccine Could Prevent 90% of Cervical Cancers
A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.
Urine Test Works for HPV Screening
Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.
Cervical Cancer Screening Tests Continue to Evolve
Be it Pap tests, HPV tests, or both, cervical cancer screening is important. This article explores screening paradigms and offers a glimpse of what's to come.
FDA Update: Bevacizumab Is Approved for Cervical Cancer
The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.
Already Had Sex? The HPV Vaccine Still Has Value
The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.
Cervical Cancer Screening Guideline Update
In light of the recent FDA approval of HPV testing for women as a screening method for cervical cancer, we discuss changing guidelines with two experts.
Pelvic Exams Have Value: Does Skipping Them Put Women at Risk?
The American College of Physicians (ACP) recommends against pelvic exams in asymptomatic, nonpregnant, adult women. Some say this is faulty logic. What say you?
By clicking Accept, you agree to become a member of the UBM Medica Community.